In the long term, characterizing the immunomodulatory capacity of tryptamine and other AHR ligands produced by normal flora will help further define the complex etiology of autoimmune disorders and potentially translate into clinical applications such microbiome-based therapies. The gene discussed is AHR; the disease is autoimmune disease.